AI assistant
Sending…
DEXCOM INC — Director's Dealing 2021
Apr 2, 2021
30198_dirs_2021-04-01_7ed0386a-7d6f-478d-a2a8-b4e5f619d7ec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2021-03-31
Reporting Person: Shrishrimal Sumi (SVP Chief Risk Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14847 | Direct |
Footnotes
F1: Included in this number are 10,599 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,872 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 1,608 of which were granted on March 8, 2019 and shall vest through March 8, 2022 and 3,046 of which were granted on May 22, 2018 and shall vest through May 22, 2021.
More from DEXCOM INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Regulatory Filings
2026
May 28
Transaction in Own Shares
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Board/Management Information
2026
Mar 2
Director's Dealing
2026
Feb 26
Board/Management Information
2026
Feb 26
Director's Dealing
2026
Feb 17